• Apigenin: From HDAC Biology to Translation

  2026-09-11

  Apigenin connects HDAC inhibition, oxidative stress, apoptosis, and network-medicine insights across oncology and neurodegeneration. This translational perspective outlines how to turn its mechanistic profile into disciplined preclinical decisions.

• Mc-Val-Cit-PABC-PNP ADC Linker Workflow

  2026-09-10

  Mc-Val-Cit-PABC-PNP is a cathepsin cleavable ADC peptide linker for research workflows that evaluate lysosomal payload release during antibody-drug conjugate synthesis. Its high DMSO solubility supports controlled organic-solvent handling, while insolubility in water and ethanol limits aqueous use; it is not intended for diagnostic, clinical, or medical applications.

• Modified Ethanol Injection for mRNA Lipoplexes

  2026-09-10

  Tang and colleagues evaluated a modified ethanol injection method for rapidly preparing mRNA lipoplexes from lipid-ethanol and aqueous mRNA phases. Screening 18 lipid combinations identified formulations that enhanced reporter expression in cells and, for the DC-1-16/DOPE/PEG-Chol composition, supported protein expression in mouse lungs and spleen after systemic administration.

• γH2AX DNA Damage Detection Kit for FLASH-RT

  2026-09-09

  Translate radiation- and treatment-induced DNA damage into measurable red γ-H2AX foci with a practical immunofluorescence workflow. The assay supports radiosensitization studies, DNA repair kinetics, apoptosis assay design, and genotoxicity assessment across mammalian cells and tissues.

• Measuring Cancer Drug Response Beyond Relative Viability

  2026-09-09

  Hannah Schwartz’s dissertation shows why relative viability and cell killing should not be treated as interchangeable measurements in cancer research. Its framework emphasizes response magnitude, timing, and orthogonal validation, providing a practical basis for designing more interpretable drug-response and apoptosis assays.

• NADH as a Redox Lens for Mechanistic Research

  2026-09-08

  NADH is more than an electron donor: it is a practical redox variable for connecting metabolism with mechanistic biology. This article explains how to integrate reduced nicotinamide adenine dinucleotide into osteoclast, mitochondrial, disease-modeling, and photocatalytic assays without confusing correlation with causation.

• Fenipentol in Chuanxiong: A CHD Mechanism Study

  2026-09-08

  The reference study distinguishes the volatile chemistry and predicted pharmacology of Chuanxiong cortex and pith rather than treating the rhizome as a uniform material. By combining SPME-GC×GC-MS, network pharmacology, pathway analysis, and molecular docking, it identifies Fenipentol among the principal cortex-associated compounds and provides a framework for tissue-specific investigation of coronary heart disease mechanisms.

• Acifran: Structural Strategy for Lipid Signaling

  2026-09-07

  Acifran is emerging as more than a receptor agonist: it is a practical mechanistic probe for comparing HCAR2/GPR109A and HCAR3/GPR109B signaling. Recent cryo-EM structures provide a rational framework for assay design, translational risk assessment, and structure-guided lipid metabolism research.

• Paclitaxel and Lysosomal Stress in Cancer Research

  2026-09-07

  Paclitaxel (Taxol) is best known for stabilizing microtubules and producing mitotic arrest, but it can also serve as a carefully controlled perturbation tool for studying organelle stress. This article connects paclitaxel assay design with new evidence for TECPR1-mediated lysosomal repair, emphasizing mechanistic controls and interpretation limits.

• KG-501 for CREB–CBP Mechanistic Assays

  2026-09-05

  KG-501 is a practical chemical probe for testing CREB–CBP and Myb–KIX transcriptional coactivator disruption in cell-based workflows. This guide translates its use in macrophage and colorectal cancer pathway studies into dose-planning, assay-selection, and troubleshooting strategies.

• Propranolol in Regeneration Research: Practical Workflows

  2026-09-04

  Use Propranolol as a controlled β-adrenergic perturbation across cardiovascular, neurobehavioral, metabolic, and exploratory inner-ear regeneration assays. This guide combines solvent handling, dose design, multiplex tissue readouts, and troubleshooting so researchers can separate receptor-mediated effects from injury, vehicle, and systemic confounders.

• Cy5 Hydrazide: Carbonyl Assays in Nanoparticles

  2026-09-04

  Cy5 hydrazide combines carbonyl-selective chemistry with far-red fluorescence for protein carbonylation labeling and biomolecule analysis. This guide focuses on a less-discussed challenge: separating true chemical labeling from nanoparticle association, aggregation, and imaging artifacts.

• ω-Agatoxin IVA TFA in Cav2.1 Workflows

  2026-09-03

  ω-Agatoxin IVA TFA enables selective interrogation of Cav2.1-dependent calcium entry, synaptic release, and seizure-related circuit activity. Its value is greatest when concentration, voltage protocol, and channel subtype are interpreted together rather than treating every toxin-sensitive current as a single P-type population.

• ATRX-Deficient Glioma and RTK Inhibitor Sensitivity

  2026-09-03

  The reference study identifies ATRX deficiency as a cellular vulnerability to multi-targeted receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma models. Its combination data further indicate that ATRX status may help interpret RTK inhibitor responses when these agents are paired with temozolomide, although clinical validation remains necessary.

• Liproxstatin-1 for Ferroptosis Research

  2026-09-02

  Liproxstatin-1 is a potent ferroptosis inhibitor for separating iron-dependent lipid damage from apoptosis and nonspecific oxidative stress. This workflow shows how to use it in GPX4-deficient cell protection, renal injury studies, and emerging salivary gland models while avoiding common assay artifacts.

8082 records 3/539 page Previous Next 12345 下5页 Last page